Schrodinger SDGR EBITDA

EBITDA at other companies

Cadence Design SystemsCDNS

$567.3M+92.0%

Simulations PlusSLP

$5.87M+108%

Recursion Pharmaceuticals, Inc.RXRX

-$116.8M+23.3%

Absci CorporationABSI

-$31.46M-10.8%

AbCellera Biologics Inc.ABCL

-$55.79M-26.5%

Relay Therapeutics, Inc.RLAY

-$90.46M-19.3%

FAQ

What is Schrodinger's EBITDA?

Schrodinger (SDGR) reported EBITDA of -$40.06M in Q2 2026.

How has Schrodinger's EBITDA changed year-over-year?

Schrodinger's EBITDA increased by 22.0% year-over-year, from -$51.37M to -$40.06M.

What is the long-term trend for Schrodinger's EBITDA?

Over 4 years (2021 to 2025), Schrodinger's EBITDA has grown at a 10.3% compound annual growth rate (CAGR), from -$108.6M to -$160.87M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.